Review: Remote disease monitoring in rheumatoid arthritis
Rheumatoid arthritis (RA), the archetypal inflammatory arthritis, remains a complex and challenging disease to manage in spite of the abundance of new therapies in the last 20 years. The unpredictable relapsing/remitting nature of RA is at odds with the current prevailing system of scheduled follow-...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-01-01
|
| Series: | Indian Journal of Rheumatology |
| Subjects: | |
| Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=7;spage=384;epage=393;aulast=MacBrayne |
| _version_ | 1797954971636858880 |
|---|---|
| author | Amy MacBrayne William Marsh Frances Humby |
| author_facet | Amy MacBrayne William Marsh Frances Humby |
| author_sort | Amy MacBrayne |
| collection | DOAJ |
| description | Rheumatoid arthritis (RA), the archetypal inflammatory arthritis, remains a complex and challenging disease to manage in spite of the abundance of new therapies in the last 20 years. The unpredictable relapsing/remitting nature of RA is at odds with the current prevailing system of scheduled follow-ups, leaving patients with RA to manage pain, flares, and medications between appointments, which may be of little value if occurring during a period of disease control. The rapid progress in the field of mobile health (mHealth) in the last 10 years has led to a proliferation of smartphone applications (apps) targeted at people with RA. Harnessing the power of smartphones to deliver remote monitoring for patients with RA has gone from an exciting possibility to an urgent necessity due to the COVID-19 pandemic. Apps developed solely by commercial providers have been found to be of limited utility in disease monitoring. However, multiple global institutions have developed mHealth technology to support remote monitoring of RA patients, utilizing asynchronous technology for patients to submit indicators of their disease activity, ranging from validated electronic patient-reported outcome measures, to innovative monitoring utilizing smartphone biosensors. This review discusses the current published evidence for mobile applications designed to facilitate remote monitoring of RA, the common barriers faced in implementing mhealth monitoring and strategies to overcome these, and potential areas for future research. |
| first_indexed | 2024-04-10T23:25:56Z |
| format | Article |
| id | doaj.art-0da8f11582104f5abb57f6066c2b944d |
| institution | Directory Open Access Journal |
| issn | 0973-3698 0973-3701 |
| language | English |
| last_indexed | 2024-04-10T23:25:56Z |
| publishDate | 2022-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Indian Journal of Rheumatology |
| spelling | doaj.art-0da8f11582104f5abb57f6066c2b944d2023-01-12T12:10:59ZengWolters Kluwer Medknow PublicationsIndian Journal of Rheumatology0973-36980973-37012022-01-0117738439310.4103/injr.injr_142_21Review: Remote disease monitoring in rheumatoid arthritisAmy MacBrayneWilliam MarshFrances HumbyRheumatoid arthritis (RA), the archetypal inflammatory arthritis, remains a complex and challenging disease to manage in spite of the abundance of new therapies in the last 20 years. The unpredictable relapsing/remitting nature of RA is at odds with the current prevailing system of scheduled follow-ups, leaving patients with RA to manage pain, flares, and medications between appointments, which may be of little value if occurring during a period of disease control. The rapid progress in the field of mobile health (mHealth) in the last 10 years has led to a proliferation of smartphone applications (apps) targeted at people with RA. Harnessing the power of smartphones to deliver remote monitoring for patients with RA has gone from an exciting possibility to an urgent necessity due to the COVID-19 pandemic. Apps developed solely by commercial providers have been found to be of limited utility in disease monitoring. However, multiple global institutions have developed mHealth technology to support remote monitoring of RA patients, utilizing asynchronous technology for patients to submit indicators of their disease activity, ranging from validated electronic patient-reported outcome measures, to innovative monitoring utilizing smartphone biosensors. This review discusses the current published evidence for mobile applications designed to facilitate remote monitoring of RA, the common barriers faced in implementing mhealth monitoring and strategies to overcome these, and potential areas for future research.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=7;spage=384;epage=393;aulast=MacBrayneapplicationmhealthremote monitoringrheumatoid arthritissmartphone |
| spellingShingle | Amy MacBrayne William Marsh Frances Humby Review: Remote disease monitoring in rheumatoid arthritis Indian Journal of Rheumatology application mhealth remote monitoring rheumatoid arthritis smartphone |
| title | Review: Remote disease monitoring in rheumatoid arthritis |
| title_full | Review: Remote disease monitoring in rheumatoid arthritis |
| title_fullStr | Review: Remote disease monitoring in rheumatoid arthritis |
| title_full_unstemmed | Review: Remote disease monitoring in rheumatoid arthritis |
| title_short | Review: Remote disease monitoring in rheumatoid arthritis |
| title_sort | review remote disease monitoring in rheumatoid arthritis |
| topic | application mhealth remote monitoring rheumatoid arthritis smartphone |
| url | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2022;volume=17;issue=7;spage=384;epage=393;aulast=MacBrayne |
| work_keys_str_mv | AT amymacbrayne reviewremotediseasemonitoringinrheumatoidarthritis AT williammarsh reviewremotediseasemonitoringinrheumatoidarthritis AT franceshumby reviewremotediseasemonitoringinrheumatoidarthritis |